Recombinant multi-species IL25 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL25 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a cytokine that shares sequence similarity with interleukin 17. This cytokine can induce NF-kappaB activation, and stimulate the production of interleukin 8. Both this cytokine and interleukin 17B are ligands for the cytokine receptor IL17BR. Studies of a similar gene in mice suggest that this cytokine may be a pro-inflammatory cytokine favoring the Th2-type immune response. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
The Alternative Names of target: IL-17e,IL-25,IL17E,IL25,Il17e,Il25,Interleukin-17E (IL-17E),Interleukin-25,RGD1561632

Target products collectionGo to IL25 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T62241-Ag-1/ GM-Tg-hg-T62241-Ag-2 Human IL25 protein Human
GM-Tg-rg-T62241-Ag-1/ GM-Tg-rg-T62241-Ag-2 Rat IL25 protein Rat
GM-Tg-mg-T62241-Ag-1/ GM-Tg-mg-T62241-Ag-2 Mouse IL25 protein Mouse
GM-Tg-cynog-T62241-Ag-1/ GM-Tg-cynog-T62241-Ag-2 Cynomolgus/Rhesus macaque IL25 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T62241-Ag-1/ GM-Tg-felg-T62241-Ag-2 Feline IL25 protein Feline
GM-Tg-cang-T62241-Ag-1/ GM-Tg-cang-T62241-Ag-2 Canine IL25 protein Canine
GM-Tg-bovg-T62241-Ag-1/ GM-Tg-bovg-T62241-Ag-2 Bovine IL25 protein Bovine
GM-Tg-equg-T62241-Ag-1/ GM-Tg-equg-T62241-Ag-2 Equine IL25 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T62241-Ag-1/ GM-Tg-hg-T62241-Ag-2; GM-Tg-rg-T62241-Ag-1/ GM-Tg-rg-T62241-Ag-2;
GM-Tg-mg-T62241-Ag-1/ GM-Tg-mg-T62241-Ag-2; GM-Tg-cynog-T62241-Ag-1/ GM-Tg-cynog-T62241-Ag-2;
GM-Tg-felg-T62241-Ag-1/ GM-Tg-felg-T62241-Ag-2; GM-Tg-cang-T62241-Ag-1/ GM-Tg-cang-T62241-Ag-2;
GM-Tg-bovg-T62241-Ag-1/ GM-Tg-bovg-T62241-Ag-2; GM-Tg-equg-T62241-Ag-1/ GM-Tg-equg-T62241-Ag-2
Products Name IL25 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IL25
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL25 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.